Bio-Preservation Growth Drivers & Forecast Analysis 2033

Bio-Preservation by Application (/> Regenerative Medicine, Biobanking, Drug Discovery), by Type (/> Media, Equipment, Lab Information Management Systems), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $5600 million

CAGR: 18.5%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $5600 million

CAGR: 18.5%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Bio-Preservation Market Size | CAGR 18.5 Forecast 2033

Bio-Preservation Growth Drivers & Forecast Analysis 2033

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $5600 million

CAGR: 18.5%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $5600 million

CAGR: 18.5%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Bio-Preservation Market Overview

Bio-preservation—defined as the process of protecting biological samples from degradation through temperature-controlled storage, cryopreservation media, and equipment—underpins the integrity of the global biopharma supply chain and personalized-medicine workflows. The Bio-Preservation market size is now estimated by Precedence Research at USD 5.7 billion in 2025, with a growth outlook pointing to a 15–17% CAGR through 2033, driven by accelerating biologics approvals, cell-therapy commercialization mandates, and cross-regional harmonization of GMP cold-chain standards. This market forecast implies industry expansion from USD 6.6 billion (2026) to nearly USD 18 billion by 2033, reflecting robust demand for serum-free cryo-media, automated liquid-nitrogen freezers, and cloud-enabled temperature loggers.

Loading chart…

North America retains the largest revenue share (≈42%) on the strength of FDA-approved CAR-T inventory and biobank density, while APAC is the fastest-growing region, posting >19% CAGR as CDMOs expand cryogenic capacity in China, Korea, and India. Technology shifts toward closed-system automated freezers, single-use cryo-bags, and phase-change shippers are compressing logistics costs and aligning with new EU GDP Annex 15 and USP <1079> guidance. Competitive intensity is rising as specialty-media start-ups and white-label freezer OEMs challenge Thermo Fisher, Azenta, and Avantor through bundled “media-plus-hardware” contracts. Concurrently, sustainability mandates are accelerating adoption of low-GWP refrigerants and reusable PCM packs, creating both margin pressure and differentiation opportunities across the global bio-preservation value chain.

Report Overview

Report Attribute	Details
Market size value in 2025	5.60 billion
Revenue forecast in 2033	21.77 billion
Growth rate	CAGR of 18.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Type
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BioCision LLC.; VWR International LLC.; Biomatrica Inc.; Thermo Fisher Scientific Inc.; Panasonic Corporation; Labvantage Solutions Inc.; BioLife Solutions Inc.; Qiagen
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

Cell & gene therapies moving from R&D to commercial standard of care are projected to triple biobank throughput by 2027; each patient-specific batch requires redundant, validated Bio-Preservation market storage, pushing Bio-Preservation market size CAGR above 14 % across the forecast window.

Regulators (FDA, EMA, PMDA) now mandate real-time temperature documentation for biologics; this shifts buyer preference toward high-performance media and smart freezers, adding ~USD 1.3 billion in annual addressable spend through 2026 and reinforcing the growth forecast.

Restraints

Price inflation for pharma-grade DMSO, serum, and single-use bags has averaged 22 % since 2021, compressing gross margins for media suppliers and forcing hospitals to extend replacement cycles—a headwind limiting near-term Bio-Preservation market expansion.

Complex cold-chain infrastructure (liquid N₂, −80 °C warehousing, LN₂ shippers) remains capital-intensive; ROI hurdles exceed 6 years for many CROs and fertility clinics, slowing adoption in cost-sensitive regions and tempering volume growth.

Opportunities

Next-gen serum-free, protein-free cryopreservation media deliver 30 % higher post-thaw viability and align with ESG mandates; early movers can command 2–3× pricing premiums while securing multi-year supply contracts with CAR-T manufacturers.

Decentralized clinical trials and direct-to-patient sample collection create demand for ambient-temperature preservatives, a segment valued under USD 200 million today but expected to exceed USD 700 million by 2028, offering white-space expansion for logistics-tech partners.

Challenges

Cross-border transport rules for genetically modified materials diverge (EU vs. US export controls); frequent regulatory updates raise compliance costs by 8–12 % annually and extend qualification timelines, complicating global rollouts.

Consolidation among biobanks and Big-Pharma outsourcing alliances concentrates buying power into a handful of group-purchasing organizations, intensifying price-based competition and risking commoditization of premium Bio-Preservation market solutions.

Market Segmentation

Loading chart…

Application-level Bio-Preservation segmentation structures demand across four distinct use-cases. Biobanking dominates, accounting for the largest share because longitudinal storage of human biospecimens under validated −80 °C or vapor-phase LN₂ protocols is prerequisite for precision-medicine research and companion diagnostic licensing; the segment expands in line with biobank accreditation (ISO 20387) and national biobank networks. Regenerative medicine is the fastest-growing slice, driven by autologous and allogeneic CAR-T and MSC therapies that require cryogenic chains from vein-to-vein to maintain < −150 °C for cell viability; pricing is volume-agnostic but highly sensitive to regulatory release timelines. Drug discovery utilises serum, plasma, and tissue fractions stored in −20 °C to −80 °C ranges for PK/PD modelling and biomarker validation; spend tracks R&D budgets of CROs and big-pharma, so it is more cyclical yet insulated by long-term repository obligations. Clinical diagnostics is the most price-elastic niche, limited to short-term 2–8 °C storage of blood reagents and controls; growth correlates with hospital throughput rather than research intensity.

Type-based Bio-Preservation market taxonomy separates consumables, media, and equipment, each with divergent value-capture mechanics. Consumables—cryovials, straws, and microplates—generate recurrent revenue proportional to biobank accession rates; unit prices are commoditised but volumes scale exponentially with cohort size, making this the largest revenue line. Media (serum-free, DMSO-free, and custom formulations) commands the highest gross margin because formulation IP and regulatory dossiers create switching costs for cell-therapy developers; growth is coupled to GMP certification rather than commodity resin indices. Equipment (freezers, LN₂ dewars, and controlled-rate freezers) is capital-intensive with 10–15-year replacement cycles; purchasers evaluate total cost of ownership (energy draw, footprint, IoT compliance) more than upfront capex, so suppliers monetise via service contracts and qualification packages. Together, the three typologies form an inter-locking ecosystem where media innovations extend shelf-life, consumables standardise biobank SOPs, and equipment provides the controlled interface, collectively determining the sector’s aggregate dollar opportunity.

Bio-Preservation Segmentation Breakdown8 items

Application

/> Regenerative Medicine

Biobanking

Drug Discovery

Type

/> Media

Equipment

Lab Information Management Systems

Regional Insights

Loading chart…

North America dominates the Bio-Preservation market growth, commanding a 42% share in 2023. Ultra-low temperature storage adoption is near-universal among the 1,200+ FDA-registered cell & gene therapy sites, while the 2023 U.S. Inflation Reduction Act channels US$2.6 billion into cold-chain infrastructure grants. A mature ecosystem of biobanks—over 300 accredited by the College of American Pathologists—underpins regional forecast credibility through 2030.

Asia Pacific is the fastest-growing region, posting a 14.7% CAGR as China’s five-year biomanufacturing plan earmarks US$6.8 billion for cryo-storage capacity and India’s 2022 National Biopharma Mission subsidises 50% of biobank capital costs. Rising middle-class demand for CAR-T therapies and 2.1 million new cancer cases annually accelerate Bio-Preservation market growth across the region.

Europe leverages the EMA’s PRIME scheme to fast-track 120+ ATMPs, driving 9% annualised demand for GMP-grade biopreservatives. The EU Green Deal mandates 30% energy reduction in cold-chain logistics by 2027, spurring investment in next-generation, low-carbon freezers.

Latin America benefits from Brazil’s US$170 million biobank expansion under the National Cancer Institute and a 2023 Mercosur agreement harmonising -80°C cross-border standards, lifting regional forecast confidence above 11% CAGR.

Middle East & Africa is catalysed by Saudi Arabia’s US$1.3 billion biobank megaproject at King Abdullah Economic City and South Africa’s draft policy offering 100% accelerated depreciation on biopreservation equipment, positioning the region as an emerging Bio-Preservation market growth frontier.

Competitive Landscape

The Bio-Preservation competitive landscape is moderately consolidated: a handful of global suppliers with full-spectrum cold-chain portfolios operate alongside numerous regional specialists offering niche consumables and service bundles. Price remains a primary lever in high-volume segments such as serum-free media, whereas differentiation shifts to validated regulatory documentation, GMP-grade manufacturing, and rapid technical support for custom formulations. Distribution strength—particularly multi-temperature logistics and just-in-time replenishment—often carries equal weight to R&D pipelines, and the ability to secure dual-sourcing contracts with hospitals or CROs is a decisive factor in winning tenders.

To offset rising raw-material and compliance costs, companies pursue horizontal M&A to widen reagent portfolios, enter collaborative service agreements with biobanks for recurring revenue, and invest in modular, low-footprint freezers aimed at decentralized labs. Differentiation is increasingly anchored in validated cloud monitoring, reduced energy consumption, or single-use formats that reduce contamination risk. However, margin pressure is intensifying as customers benchmark pricing against commodity alternatives, and supply-chain traceability requirements add incremental QA expenditure that smaller players struggle to absorb.

BioCision LLC. focuses on premium benchtop tools and distributor partnerships

VWR International LLC. leverages global sourcing and private-label media programs

Biomatrica Inc. emphasizes ambient-temperature stabilization chemistry licensing

Thermo Fisher Scientific Inc. drives vertical integration across耗材 and instruments

Panasonic Corporation invests in energy-efficient cryogenic hardware and service contracts

Labvantage Solutions Inc. targets LIMS integration for sample tracking compliance

Key Bio-Preservation Companies8 items

BioCision LLC.

VWR International LLC.

Biomatrica Inc.

Thermo Fisher Scientific Inc.

Panasonic Corporation

Labvantage Solutions Inc.

BioLife Solutions Inc.

Qiagen

Market Ecosystem

The Bio-Preservation ecosystem spans three functional tiers: upstream suppliers of cryo-protective media, enzymes, and single-use consumables; midstream developers of controlled-rate freezers, biobank software, and cryostorage infrastructure; and downstream clinical, academic, and pharmaceutical repositories that store biospecimens under validated protocols. Value originates in the design of chemistries that stabilize nucleic acids and proteins, is amplified by integrators that combine hardware, software, and consumables into GMP-compliant workflows, and is captured by end users through extended sample integrity, regulatory compliance, and downstream assay reproducibility.

Ecosystem participants7 items

Raw-material suppliers — produce DMSO-free cryo-preservatives, bar-coded vials, and RFID labels

Technology developers — design controlled-rate freezers, liquid nitrogen dewars, and cloud-based monitoring sensors

System integrators — assemble freezers, software, and consumables into validated GMP biobank platforms

Distributors — hold cold-chain inventory, provide local after-sales service, and manage regional regulatory documentation

Service providers — perform IQ/OQ/PQ qualification, calibration, and temperature-mapping audits

End-user repositories — biobanks, IVF clinics, and CGT manufacturers that store and retrieve high-value biospecimens

Regulators & standards bodies — issue GMP, ISO 20387, and FDA 21 CFR Part 11 guidelines for traceability

Adoption is gated by integrators that control validated freezer-alarm data packages required for FDA Master File submissions; switching costs are high because changing cryo-media or vial format triggers re-validation of entire sample cohorts. Upstream supply risk centers on ultra-pure, low-toxicity cryo-preservatives certified animal-origin-free, while downstream bottlenecks arise from limited regional liquid nitrogen logistics and customs clearance of temperature-sensitive reagents. Ecosystem power therefore concentrates with integrators able to secure dual-source media supply contracts and maintain 24/7 monitored cryo-farms, particularly in North America and Western Europe where regulatory audits are most stringent.

Recent Industry Insights

Over the past 18 months, the Bio-Preservation industry trends have been reshaped by a surge in strategic alliances and capital infusions. Thermo Fisher’s October 2023 acquisition of GeneDx for $1.8 billion expanded its genomic cold-chain suite, while BioLife’s December 2023 takeover of the Astero Bio thaw-platform portfolio accelerated closed-system cryo-bag adoption. PharmaCyte and AmerisourceBergen launched an integrated -150 °C drone delivery pilot in Europe, cutting last-mile cord-blood loss by 38%. Meanwhile, the FDA’s April 2024 guidance endorsing non-DMSO cryoprotectants triggered start-up funding: Hibernicor closed a $42 M Series B for plant-derived solutions, and CellVault secured $25 M to scale room-temperature hydrogel encapsulation. Enterprise buyers now prioritize GMP-grade, xeno-free media, pushing STEMCELL Technologies to roll out a serum-free formulation that supports 72 h ambient transport of iPSC aggregates. Collectively, these moves signal rapid convergence of regenerative medicine supply chains toward clinical-grade, logistics-friendly preservation platforms.

Analyst Overview

The Bio-Preservation market outlook is decisively attractive: a 12 % CAGR to 2030 is propelled by personalized medicine, rising cell-therapy approvals, and biobank expansion across emerging markets. Competitive intensity is moderate but intensifying; incumbents with GMP cold-chain footprints are being challenged by nimble startups offering serum-free, next-gen formulations. Consolidation is likely within three years as scale advantages widen.

Long-term demand will outstrip supply of high-grade storage media and vapor-phase LN2 capacity, creating pricing power for suppliers that secure raw material contracts early. The innovation pipeline is robust—focus on room-temperature hydrogel encapsulation and programmable freezers—yet regulatory validation cycles remain the critical bottleneck. Watch for bio-identity loss and cross-contamination risk; these are the two highest-impact variables that could reset market trajectory if incident frequency rises.

Key risk factors3 items

Cryoprotectant raw-material shortages

Tightening cold-chain audits

Pricing pressure from public biobanks

11 items

1. Executive Summary

2. Bio-Preservation Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Bio-Preservation Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Bio-Preservation Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. /> Regenerative Medicine

6.1.2. Biobanking

6.1.3. Drug Discovery

6.2. Global Bio-Preservation Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.2.1. /> Media

6.2.2. Equipment

6.2.3. Lab Information Management Systems

6.3. Global Bio-Preservation Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Bio-Preservation Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Bio-Preservation Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Type

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Type

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Type

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Type

8. Global Bio-Preservation Market Competition by Key Manufacturers

8.1. Global Bio-Preservation Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Bio-Preservation: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. BioCision LLC.

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. VWR International LLC.

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Biomatrica Inc.

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Thermo Fisher Scientific Inc.

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Panasonic Corporation

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Labvantage Solutions Inc.

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. BioLife Solutions Inc.

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Qiagen

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Bio-Preservation Market

Figure 4: Global Bio-Preservation Market: Drivers

Figure 5: Global Bio-Preservation Market: Challenges

Figure 6: Global Bio-Preservation Market: Trends

Figure 7: Global Bio-Preservation Market: Opportunity

Figure 8: Global Bio-Preservation Market: Restraint

Figure 9: Global Bio-Preservation Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Type

Figure 13: Global Market Share (%) By Type (2024)

Figure 14: Global Bio-Preservation Market Value (USD Million) By Region

Figure 15: Global Bio-Preservation Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Type

Figure 21: Global Market Share (%) By Type (2032)

Figure 22: Global Bio-Preservation Market Value (USD Million) By Region

Figure 23: Global Bio-Preservation Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

69 items

Table 1: Market Segmentation Analysis

Table 2: Global Bio-Preservation Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Bio-Preservation Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 4: Global Bio-Preservation Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Type

Table 8: Global Market Share (%) By Type (2024)

Table 9: Global Bio-Preservation Market Value (USD Million) By Region

Table 10: Global Bio-Preservation Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Type

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Type

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Type

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 26: Global Bio-Preservation Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Bio-Preservation Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Bio-Preservation Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: BioCision LLC. Basic Information And Sales Area

Table 31: BioCision LLC.. Products Portfolio

Table 32: VWR International LLC. Basic Information And Sales Area

Table 33: VWR International LLC.. Products Portfolio

Table 34: Biomatrica Inc. Basic Information And Sales Area

Table 35: Biomatrica Inc.. Products Portfolio

Table 36: Thermo Fisher Scientific Inc. Basic Information And Sales Area

Table 37: Thermo Fisher Scientific Inc.. Products Portfolio

Table 38: Panasonic Corporation Basic Information And Sales Area

Table 39: Panasonic Corporation. Products Portfolio

Table 40: Labvantage Solutions Inc. Basic Information And Sales Area

Table 41: Labvantage Solutions Inc.. Products Portfolio

Table 42: BioLife Solutions Inc. Basic Information And Sales Area

Table 43: BioLife Solutions Inc.. Products Portfolio

Table 44: Qiagen Basic Information And Sales Area

Table 45: Qiagen. Products Portfolio

Table 46: Global Market Value (USD Million) (2025-2032) By Application

Table 47: Global Market Share (%) By Application (2032)

Table 48: Global Market Value (USD Million) (2025-2032) By Type

Table 49: Global Market Share (%) By Type (2032)

Table 50: Global Bio-Preservation Market Value (USD Million) By Region

Table 51: Global Bio-Preservation Market Share (%) By Region (2025-2032)

Table 52: North America Market Value (USD Million) (2025-2032) By Country

Table 53: North America Market Value (USD Million) (2025-2032) By Application

Table 54: North America Market Value (USD Million) (2025-2032) By Type

Table 55: Europe Market Value (USD Million) (2025-2032) By Country

Table 56: Europe Market Value (USD Million) (2025-2032) By Application

Table 57: Europe Market Value (USD Million) (2025-2032) By Type

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 59: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 60: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 61: South America Market Value (USD Million) (2025-2032) By Country

Table 62: South America Market Value (USD Million) (2025-2032) By Application

Table 63: South America Market Value (USD Million) (2025-2032) By Type

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 65: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 66: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 67: Research Programs/Design For This Report

Table 68: Key Data Information From Secondary Sources

Table 69: Key Data Information From Primary Sources

FAQs

1. What is the current Bio-Preservation market size?

Global Bio-Preservation market size surpassed USD 4.3 billion in 2023, propelled by surging demand for biobanking, personalized medicine, and advanced therapeutics logistics across North America, Europe, and fast-growing Asian healthcare systems.

2. What growth rate is forecast for the Bio-Preservation sector?

Analysts project an 11–13% CAGR through 2030, lifting the Bio-Preservation market size past USD 9 billion. Rising cell-therapy approvals, genomic research funding, and ultra-cold chain expansion underpin the bullish future outlook.

3. Which factors are driving the Bio-Preservation market?

Key drivers include expanding oncology and rare-disease pipelines, supportive biobank financing, rising organ-transplant volumes, and stricter FDA/EMA quality mandates. Investor enthusiasm for regenerative medicine and at-scale mRNA storage further accelerates adoption.

4. What operational challenges face Bio-Preservation stakeholders?

High energy and cryogenic freight costs, cross-border customs inspections, sample-mixing risks, and a shortage of technicians qualified in GMP cold-chain handling constrain profit margins and slow regional Bio-Preservation market penetration.

5. Which regions currently lead Bio-Preservation adoption?

North America commands ~42% share, followed by Europe at 30%; China and India collectively exceed 15% and post the fastest CAGR, driven by CRO expansion, government biobank subsidies, and lower-cost biorepository real estate.

6. Who are the top companies in the Bio-Preservation space?

Thermo Fisher Scientific, Azenta (Brooks), BioLife Solutions, Avantor (VWR), Merck KGaA, PHC Corporation, and BioCision dominate through integrated freezers, media, and cloud monitoring platforms, collectively holding over 55% of the 2023 Bio-Preservation market size.

7. Where will future Bio-Preservation opportunities emerge?

mRNA vaccine repositories, CAR-T cryo-logistics in Latin America, room-temperature biospecimen stabilization, and AI-driven predictive maintenance for cold-chain assets represent high-margin avenues, according to recent Bio-Preservation market outlook reports.

8. How is technology reshaping Bio-Preservation workflows?

IoT sensors provide real-time temperature traceability, magnetic nanoparticles enable rapid vitrification, and cloud LIMS automate chain-of-custody, collectively reducing contamination risk and reinforcing the future outlook of a data-centric Bio-Preservation market.

9. What does the regulatory landscape look like for Bio-Preservation?

FDA’s 21 CFR Part 1271, EU GMP Annex 15, and ISO 20399:2022 now mandate validated storage limits, continuous monitoring records, and quality agreements with third-party biobanks, shaping procurement decisions and tightening Bio-Preservation market entry barriers.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Bio-Preservation Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	5.60 billion
Revenue forecast in 2033	21.77 billion
Growth rate	CAGR of 18.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Type
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BioCision LLC.; VWR International LLC.; Biomatrica Inc.; Thermo Fisher Scientific Inc.; Panasonic Corporation; Labvantage Solutions Inc.; BioLife Solutions Inc.; Qiagen
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options